cis-platinum and etoposide combination chemotherapy of advanced non-oat cell bronchogenic carcinoma
Authors:
- 1 August 1983
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 11 (1) , 35-37
Abstract
Summary From December 1981 to November 1982, a consecutive series of 37 patients with advanced non-oat cell bronchogenic carcinoma were treated with cis-platinum and etoposide in doses of 20 mg/m2 and 75 mg/m2, respectively, for 5 consecutive days every 3 weeks. Among the 33 evaluable patients, one complete response, 11 partial responses, five minor responses, seven unchanged states, and nine cases of progression were noted. Median duration of response was 30+ weeks. Toxicity was significant, but no treatment-related deaths were encountered. Combined cis-platinum and etoposide can provide significant palliation in approximately one-third of patients with the doses and schedule used.Keywords
This publication has 11 references indexed in Scilit:
- Efficacy study of intensive cis-platin therapy in advanced non-small cell bronchogenic carcinomaCancer, 1982
- Etoposide as single agent and in combination chemotherapy of bronchogenic carcinomaCancer Treatment Reviews, 1982
- Treatment of inoperable non-small-cell bronchogenic carcinoma with etoposide and cis-platinumCancer Treatment Reviews, 1982
- Etoposide and cis-platinum in non-small-cell bronchogenic carcinomaCancer Treatment Reviews, 1982
- PHASE-II TRIAL OF VP-16-213 IN NON-SMALL-CELL LUNG-CANCER1982
- Reporting results of cancer treatmentCancer, 1981
- High-dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: a phase II clinical trial of the EORTC Lung Cancer Working Party (Belgium).1980
- Evaluation of response criteria in advanced lung cancerCancer, 1979
- cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.1979
- VP-16-213 CHEMOTHERAPY FOR ADVANCED SQUAMOUS-CELL CARCINOMA AND ADENOCARCINOMA OF LUNG1978